Moneycontrol PRO

you are here: HomeNewsBusinessEarningsMixed Q3 nos for pharma so far: Here's what you should buy

SHOW NAMES

Trending Topics

business

Mixed Q3 nos for pharma so far: Here's what you should buy

Hitesh Mahida is bullish on Cipla, Glenmark and Dr Reddy‘s Laboratories from the large cap pharma space and suggests caution on Lupin for now.

first published: Feb 13, 2015 11:22 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347